Clinical trial
6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus� Both plus Mealtime Insulin in Patients with Type 2 Diabetes Mellitus with a 6-month Safety Extension
Change in HbA1c from baseline to endpoint (scheduled month 6)
| Category | Value |
|---|---|
| Study start date | 2011-08-22 |